Precigen, Inc. Additional Paid In Capital

Additional Paid In Capital of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Additional Paid In Capital growth rates and interactive chart.


Highlights and Quick Summary

  • Additional Paid In Capital for the quarter ending March 31, 2022 was $1.99 Billion (a -1.53% decrease compared to previous quarter)
  • Year-over-year quarterly Additional Paid In Capital decreased by -1.28%
  • Annual Additional Paid In Capital for 2021 was $2.02 Billion (a 7.22% increase from previous year)
  • Annual Additional Paid In Capital for 2020 was $1.89 Billion (a 7.68% increase from previous year)
  • Annual Additional Paid In Capital for 2019 was $1.75 Billion (a 1.74% increase from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Additional Paid In Capital of Precigen, Inc.

Most recent Additional Paid In Capitalof PGEN including historical data for past 10 years.

Interactive Chart of Additional Paid In Capital of Precigen, Inc.

Precigen, Inc. Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $1,991.67
2021 $2,022.7 $2,020.25 $2,017.41 $2,013.76 $2,022.7
2020 $1,886.57 $1,838.92 $1,802.41 $1,797.45 $1,886.57
2019 $1,752.05 $1,745.18 $1,737.45 $1,732.61 $1,752.05
2018 $1,722.01 $1,552.38 $1,504.36 $1,492.92 $1,722.01
2017 $1,397.01 $1,370.92 $1,355.96 $1,323.71 $1,397.01
2016 $1,325.78 $1,310.98 $1,297.1 $1,283.53 $1,325.78
2015 $1,249.56 $1,233.5 $948.92 $1,074.94 $1,249.56
2014 $843.0 $835.33 $797.52 $788.06 $843.0
2013 $743.08 $741.32 $0.0 $743.08
2012 $0.0 $0.0
2011 $0.0

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology